Skip to main content

HPLC fingerprint of flavonoids, enzyme inhibition and antioxidant activity of Newbouldia laevis stem-bark: an in vitro and in silico study



Medicinal plant contains multiple bioactive compounds with therapeutic potentials. Due to their availability, affordability, and minimal known side effects, they are widely practiced. Identification, quantification, and establishment of their interaction with physiological enzymes help in the standardization of plant-based medicinal extracts. In this study, gas chromatography/flame ionization detector (GC–FID) and high-performance liquid chromatography (HPLC) analysis were used to determine the bioactive components in the ethanol extract of Newbouldia laevis stem bark. The antioxidant activity of the extract was determined. Enzyme inhibitory potency of the flavonoids’ components was investigated against acetylcholinesterase, butyrylcholinesterase, phospholipase A2, α-glucosidase, and α-amylase.


Analysis of ethanol extract of N. laevis stem-bark revealed alkaloids (0.37%), tannins (1.82 mg/TEq/g), flavonoids (5.85 mg/QEq), steroids (0.11 mg/10 g) and glycosides (0.08 mg/10 g). The HPLC fingerprint of flavonoids showed high concentrations (mg/100 g) of catechin (47.11), apigenin (15.68), luteolin (18.90), kaempferol (41.54), and quercetin (37.64), respectively. In vitro 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging ability of the extract was exhibited at 150 and 200 mg/mL, respectively. At 300 mg, most in vitro antioxidant potentials (lipid peroxidation, metal chelating ability, hydroxyl, nitric oxide, sulfide oxide radicals scavenging abilities) were obtained. The extract showed varying inhibitory abilities (> 50%) on acetylcholinesterase, butyrylcholinesterase, phospholipase A2, α-glucosidase and α-amylase at 300 mg/mL, IC50 of 129.46, 237.10, 169.50, 251.04 and 243.06 mg/mL, respectively, with inhibition constants (Ki) of 3.92, 1.63, 1.11, 2.95 and 2.11. Results showed an affinity for the targeted enzymes with free energies higher than the standard drugs.


The results revealed that the N. laevis stem bark possesses antioxidant activity and enzyme inhibitory activity on the physiological enzyme that has been implicated in diabetes. In vitro and in silico inhibition of these physiological enzymes by extract suggests that the stem bark can be effective in ameliorating the complications associated with diabetes mellitus.


Diabetes (hyperglycemia) is characterized by a prolonged high concentration of blood glucose in the blood, resulting from defects with insulin or insulin receptors [1]. It is associated with several complications such as neuropathy and retinopathy, while excessive reactive oxygen species, reduced antioxidant status and hyperglycemia increase the diseased condition [2]. International Diabetes Federation [3] predicted about 642 million new diabetes cases by 2040. Type 2 diabetes mellitus has become a universal health crisis that threatens several aspects of nationhood, including the economy and the health care system (United Nations organization, 2001). The disease is associated with several complications including inflammation and Alzheimer's disease [4], where insulin resistance has been implicated to be a risk factor for Alzheimer disease development [5]. They are pieces of evidence that inflammation is an essential pathogenesis process of diabetes, and diabetes-related vascular complications [4], thus inhibiting or targeting inflammatory processes could manage complications associated with diabetes and its progression.

Phospholipase A2 is responsible for the formation of inflammatory mediators that control physiological processes such as neuroinflammation and oxidative stress [6]. This enzyme is implicated in Alzheimer’s disease pathogenesis [6]. Typically, diabetes is characterized by prolonged hyperglycemia, which occurs as a result of insulin insensitivity in the modulation of plasma glucose concentration. Thus, the pharmacological control of carbohydrate metabolizing enzymes could aid in ameliorating the rise in plasma glucose concentration. α-Glucosidase and phosphatase are important physiological enzymes that aid in the absorption of sugars by breaking complex carbohydrates to yield glucose, and their inhibition would lead to reduction in blood glucose [7].

Plants have been the source of several agents used in the management of different diseased conditions, diabetes inclusive [8], and N. laevis has been used [9], due to the high cost, adulteration and unavailability of the orthodox drugs. Though, there is a dearth of information on the using N. laevis stem-bark in Diabetes mellitus management.

Newbouldia laevis is a perennial plant found in several communities of Nigeria as a hedge to mark boundaries and for its ornamental qualities (Tropical Plant Database, 2019) and commonly known locally as Akoko (Yoruba) Ogilishi (Igbo) and Ikhimi (Edo). Several pharmacological activities that have been attributed to the plant extract include antibacterial [10, 11] and antioxidant activity [12]. Also, the extract is used in treating constipation and bile [13]. Researchers are employing computational techniques (in silico study) in drug discovery, authentication and development, due to their more convenience and economical, which has made it a widely accepted technique [14].



2,2-diphenyl-1-picrylhydrazyl, Butyrylcholine iodide, Ascorbate, Sulfanilamide, Acetylcholine iodide, 5,5′-dithio-bis (2-nitrobenzoic acid) (Sigma Aldrich, Germany) were some of the analytical chemicals used.

Sample collection

The stem of N. laevis was plucked on 2 October 2021 from a farm in Edem-Ani, Nsukka Local government Area, Southeast Nigeria. The plant was identified by Mr Felix Nwafor, Plant Science and Biotechnology Department, as Newbouldia laevis G. Don. (Sapotaceae) with voucher number PCG/UNN/0359. This study was approved by the faculty of biological science ethical clearance committee with reference Number FBS/2022/00183.

Extraction of N. laevis phytochemicals

The extract was prepared using 500 g of the dried, pulverized sample and 1000 mL of an absolute ethanol solution by cold maceration at room temperature. The mixture was shaken intermittently for 72 h and filtered through Whatman filter paper number 1 (pore size 11 mm). The final extract was concentrated on rotary vacuum evaporator (R215, Buchi, Flawil, Switzerland) at 45 °C and reduced pressure. The dried extract was kept in a refrigerator at − 4 °C.

Phytochemicals analysis by GC-FID

The quantitative analysis of phytochemicals was performed on a BUCK M910 Gas chromatography equipped with a flame ionization detector. A RESTEK 15-m MXT-1 column (15 m × 250 um × 0.15 um) was used. Phytochemicals were quantified using the area and the mass of internal standard.

HPLC analysis of N. laevis flavonoids

The flavonoid content of N. laevis was determined using high-performance liquid chromatography (HPLC) (Hangzhou-LC-8518, Zhejiang, China). Specifically, the HPLC ultraviolet (UV) detector supported by N200 chromatography software helped to establish the chemical constituents of the flavonoid’s contents. The HPLC instrument operated with a low-pressure gradient, solvent delivery pump, high-pressure switching valve, as well as high-sensitivity UV detector. Column size was 150 × 4.6 mm, with an injected sample volume of ~ 40 mL. Mobile phase was set for flavonoids (Acetonitrile/Methanol/Water/THF, 70:20:8:2), using wavelength (Lamda maximum) of 280 nm, column temperature of ~ 40 °C, and run time of ~ 20 min. Results of flavonoids were expressed as μg/100 mL. The flavonoid components of the N. laevis extract was identified by comparing their retention time (RT) of the peaks with that of know reference standards.

In vitro antioxidant activity

2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging potential.

DPPH scavenging power of Newbouldia laevis stem-bark was determined by the method [15]. The radical scavenging potential was estimated using the equation below;

$${\text{DPPH radical scavenging}}\;(\% ) = \frac{{{\text{Control absorbance}} - {\text{Sample absorbance}}}}{{{\text{Control absorbance}}}} \times 100.$$

Determination of OH* scavenging power

The determination of OH*(hydroxyl radical) scavenging power was described by Jin et al. [16]. The absorbance of the mixture was read at 536 nm. The OH* scavenging power was calculated as follows: Scavenging activity (%) = (Abs. sample − Abs. blank)/(Abs0 − Abs. blank) × 100. where Abs0 is the absorbance of the deionized water instead of H2O2 and sample in the assay system.

SO* scavenging assay

SO* (superoxide radical) scavenging power was determined according to [17] methods. The absorbance was read at 560 nm after 20 min. The percentage inhibition of superoxide generation was estimated.

NO* scavenging power

The determination of NO* (nitric oxide radical) scavenging power of the extract was as described by Sangameswaran et al. [18]. The reference standard used was ascorbic acid.

$${\text{Percentage of inhibition}} = \left[ {\left( {Ao - A1} \right)/Ao} \right] \times 100;$$

where Ao is control absorbance and A1 is sample absorbance.

Ferric cyanide (Fe3+) reducing antioxidant power assay

Ferric cyanide reducing power of the extracts was measured by absorbance measurement of the formation of the Perl's Prussian Blue complex following the addition of excess Fe3+ at 700 nm [18].

Acetylcholinesterase and butyrylcholinesterase inhibitory activity assay

Acetylcholinesterase (AchE) and butyrylcholinesterase (BuchE) inhibition were assayed using [19] methods. The absorbance was read at 412 nm. The percentage enzyme inhibition was calculated as follows; Acetylcholinesterase and butyrylcholinesterase activities were calculated with the formula.

$${\text{AChE activity}} \;\% = \frac{Ao - A1}{{Ao}} \times 100;\quad {\text{BChE activity}}\;\% = \frac{Ao - A1}{{Ao}} \times 100$$

where Ao is the control absorbance and A1 is the sample absorbance.

Assay of phospholipase A2

Phospholipase A2 (PLA2) activity was as described by (Agatemor et al., 2019). The enzyme was extracted from Aspergillus flavus cultured on nutrient agar for 7 days, homogenized and centrifuged at 6000 rpm for 30 min. The assay was initiated by adding 0.5 mL of the Newbouldia laevis stem-bark, 0.3 mL of the substrate and 0.2 mL of the enzyme preparation. The reaction mixture stood at 37 °C for 60 min, after which the resulting mixture was centrifuged at 6000 rpm for 30 min, and the absorbance was taken at 418 nm. The standard inhibitor used was Prednisolone. Enzyme activity inhibition was calculated:

$$\% \;{\text{Inhibition}} = 1 - \frac{{{\text{Enzyme activity of test sample}}}}{{{\text{Enzyme activity of Control}}}} \times 100.$$

α-amylase inhibition

Inhibition of α-amylase activity was carried out by [20] method, using 100, 200, 300 and 500 mg/mL of the extract. The absorbance was read and recorded at 540 nm. Acarbose (different concentrations) was used as a positive control.

$${\text{Percentage}}\;{{(\% )}}\;{\text{amylase inhibition}} = \left[ {\left( {{\text{AControl}}540\;{\text{ASamples}}540{\text{nm}}} \right)/{\text{AControl}}540{\text{nm}}} \right)] \times 100.$$

Assay of α-glucosidase activities

Inhibition of α-glucosidase activity was determined using the procedure of [21] with some modifications. The amount of p-nitrophenyl produced after enzymatic dephosphorylation was estimated by measuring the absorbance at 405 nm using JENWAY 6404. The inhibition (%) was calculated as (Ac − As)/Ac 100%, where Ac is the absorbance of the control and As is the absorbance of the sample. Acarbose was used as a positive control.

Bioinformatics tools

Bioinformatics tools such as AutoDock Vina [22], Open Babel GUI [23], PROTOX-II (, Discovery Studio 2016 client and Chimera 1.8.1 [24] were utilized in this study.

Retrieval and preparation of target protein

The crystallized forms of the proteins (enzymes), Phospholipase A2 protein data bank identification number (PDB ID: 1G4I), Acetylcholinesterase (PDB ID: 2ACE), α-Glucosidase (PDB ID: 2JKP), α-amylase (PDB ID: 2QMK) and Butyrylcholinesterase (PDB ID: 6QAE) were retrieved from the Protein Data Bank ( Bovia: Discovery studio 2016 client was used to prepare the proteins for molecular docking study. The active sites were predicted based on the co-crystallized ligand (internal ligand). The grid was also adjusted through manual visualization.

Ligand preparation

The phytocompounds, Apigenin, Catechin, Isorhamnetin, Kaempferol, Quercetin, Naringin and Luteolin were selected from the results of the HPLC analysis and in vitro studies carried out using the extract. These phytocompounds exhibited a strong effect on our targeted proteins as shown in the in vitro studies. The two-dimensional structures of these phytocompounds and used standard drugs (Galantamine, Prednisolone and Acarbose) were downloaded from Pubchem ( in.sdf format and were converted to protein data bank (PDB) format using Open Babel Tool.

Molecular docking of phytocompounds of N. laevis with targets proteins

Molecular docking studies of the selected ligands (phytocompounds) against the targeted proteins were performed. These studies were carried out using AutoDock vina tool 1.5.7 [22]. A detailed visualization and comparison of the docked sites of the target proteins with the selected ligands were carried out by Discovery Studio 2016 client and Chimera 1.8.1 [24].

Toxicity prediction of phytocompounds and standard drugs

The drug-likeness and toxicity properties of the Phyto-compounds were carried out by uploading their smile format on PROTOX-II webservers (Charite University of Medicine, Institute for Physiology, Structural Bioinformatics Group, Berlin, Germany).

Data analysis

The statistical analysis was carried out using the statistical program GLM model (SAS Institute, Cary, NC, USA, 2001). The means of values were compared using independent t-test of significance (p < 0.05).


Phytochemical analysis

Alkaloids (0.37%), tannins (1.82 mg/TEq/g), flavonoids (5.85 mg/QEq), steroids (0.11 mg/100 g) and glycosides (0.08 mg/10 g), respectively, were quantified in the stem-bark extract of N. laevis. Terpenoids and saponins were not identified (Table 1). The presence of flavonoids, alkaloids and tannins is an indication that the extract possesses some pharmacological activities.

Table 1 Phytochemical analysis

HPLC flavonoids fingerprint of N. laevis stem-bark extract

The HPLC profile of the flavonoids content of the stem-bark extract showed (+)-catechin (47.11 mg/100 g), apigenin (15.68 mg/100 g), resveratrol (3.80 mg/100 g), genistein (1.22 mg/100 g), daidzein (6.77 mg/100 g), butein (5.35 mg/100 g), naringenin (8.23 mg/100 g), biochanin (8.41 mg/100 g), luteolin (18.90 mg/100 g), kaempferol (41.54 mg/100 g), (−)-epicatechin (5.77 mg/100 g), (−)-epigallocatechin (1.63 mg/100 g), gallocatechin (1.45 mg/100 g), quercetin (37.64 mg/100 g), (−)-epicatechin-3-gallate (2.83 mg/100 g), (−)-epigallocatechin-3-gallate (2.73 mg/100 g), isorhamnetin (11.83 mg/100 g), robinetin (5.94 mg/100 g), myricetin (7.26 mg/100 g), baicalein (5.46 mg/100 g), nobiletin (3.72 mg/100 g), tangeretin (2.73 mg/100 g), artemetin (2.13 mg/100 g), silymarin (1.87 mg/100 g), naringin (15.49 mg/100 g) and hesperidin (2.47 mg/100 g). The extract had a high concentration of flavonoids as evidenced by the HPLC fingerprint. Especially (+)-catechin (47.11 mg/100 g), apigenin (15.68 mg/100 g), biochanin (8.41 mg/100 g), luteolin (18.90 mg/100 g), kaempferol (41.54 mg/100 g), (−)-epicatechin (5.77 mg/100 g), quercetin (37.64 mg/100 g), isorhamnetin (11.83 mg/100 g), robinetin (5.94 mg/100 g), myricetin (7.26 mg/100 g) and naringin (15.49 mg/100 g) (mg/100 g) as shown in Fig. 1. The HPLC data is presented in the supplementary material (Additional file 1: Table S1). Some of these flavonoids have been established to possess various pharmacological activities.

Fig. 1
figure 1

HPLC flavonoids fingerprint of N. laevis stem-bark extract

DPPH scavenging, antioxidant activity and metal chelating ability of ethanol stem-bark extract of N. laevis

Another important potential of medicinal plants is their power to mop up radicals generated in vitro by DPPH. DPPH radical scavenging power of the extract of N. laevis exhibited a concomitant dose-dependent scavenging potential (Fig. 2), except at 500 mg when a drastic decrease in the scavenging ability was obtained. A non-significant increase in the scavenging power of the extract at 150 and 200 mg, when compared to Vitamin C. N. laevis extract, showed high DPPH radical scavenging power (Fig. 2).

Fig. 2
figure 2

in vitro DPPH scavenging activity of ethanol stem-bark extract of N. laevis

Table 2 shows the antioxidant potential of the stem-bark extract of N. laevis. There was a significant difference in the metal chelating ability of this extract (p > 0.05) among 100, 200 and 500 mg/mL, when compared to 300 mg/mL (53.94) and Vit C (59.33%), respectively.

Table 2 Antioxidant potentials of Newbouldia laevis stem-bark extract

A similar result was obtained for the metal chelating ability of the extract, where 300 mg showed a significantly higher (p > 0.05) chelating ability than other concentrations studied.

Furthermore, the OH* scavenging ability and SO* radical scavenging ability showed similar activity. At 100, 200, 300 and 500 mg, the ferric reducing potential showed a concentration-dependent increase in electron transfer rate (Table 2). The percentage OH* scavenging power of the extract at lower concentrations of 100 and 200 mg/mL was 34.12 and 38.59%. At 300 mg/mL, 60.27% of scavenging ability was obtained, though the percentage scavenging ability of the extract reduced to 44.53% at 500 mg/mL of the extract. The percentage inhibition of hydroxyl radicals by the plant extract was low (p < 0.05) when compared to the standard (Ascorbic acid) gave 86.41% inhibition. Among the concentrations used, 300 mg/mL gave the highest scavenging ability, by mopping up more than 60% of the radicals generated in vitro.

Low concentrations of the extract gave a higher percentage nitric oxide radical scavenging ability of 75.18 and 77.20% at 100 and 200 mg/mL of the extract, respectively. The subsequent increase in the extract concentration to 300 and 500 mg/mL gave 68.40 and 62.50% inhibition of the nitric oxide radical generation (Table 2). There was a non-significant (p < 0.05) difference among the extract concentrations studied, though there was a significant increase (p > 0.05) in the percentage inhibition of nitric oxide radical scavenging ability at 300 and 500 mg/mL and the Ascorbic acid. Furthermore, the ability to inhibit lipid peroxidation in vitro was determined at 100, 200, 300 and 500 mg/mL. 44.50, 47.96, 53.94 and 36.39 percentage inhibition were obtained, respectively (Table 2). 300 mg/mL gave the highest inhibition of lipid peroxidation, with other concentrations producing lower than 50% of lipid peroxidation inhibition. 100 mg of the extract showed the highest scavenging ability of nitric oxide radical than other radical species, while for lipid peroxidation, hydroxyl radical and FRAP it could not produce 50% inhibition as shown in Table 2.

Similarly, NO* scavenging power of 77.20% was the highest inhibition of the radical species obtained by 200 mg of the extract, while 56.11 > 52.41 > 50.40 were obtained for the scavenging of metal chelating ability, FRAP and SO* radical scavenging ability.

Enzyme inhibitions potentials of Newbouldia laevis stem-bark extract

This study investigated the in vitro bioactivity of Newbouldia laevis stem-bark on acetylcholinesterase, butyrylcholinesterase, α-amylase, phospholipase A2, antioxidant potential and α-glucosidase enzymes. The stem-bark extracts exerted varying degrees of inhibition on acetylcholinesterase (AchE), butyrylcholinesterase (BuchE), phospholipase A2, α-glucosidase and α-amylase. The percentage inhibition of cholinesterases was between 58 and 89.71 at different concentrations of the extract as shown in Table 3. At 100 mg/mL, 58.12 and 60.38% of AchE and BuchE inhibitions were obtained, with Ki of 3.92 and 1.63, respectively, which were significantly low (p < 0.05), compared to the standard inhibitor (89.76%) galantamine. Subsequently, high inhibition of PLA2 activity was obtained at all concentrations of the extract studied (Table 4), with an inhibition constant (Ki) of 1.11. The inhibition constant (Ki) measures the strength of an inhibitor, the smaller the constant, the stronger the inhibition [25]. There was a non-significant difference between the inhibition of extract and that of prednisolone (94.76%). At 100 mg/mL, 65.20 and 55.66 percentage inhibition of the enzymes were obtained, and 65.19, 69.84 and 71.21 percentage inhibition were obtained at the concentrations of 200, 300 and 500 mg/mL, with Ki of 2.95 and 2.11, respectively.

Table 3 Enzyme inhibitions potentials of Newbouldia laevis stem-bark extract
Table 4 Inhibitory kinetics of stem-bark extract on some enzymes

From the Ki obtained, N. laevis extract inhibited α-amylase more than α-glucosidase. At 100-300 mg, there was a significant increase when compared to Acarbose, a standard α-glucosidase inhibitor (87.51%). At 200, 300 and 500 mg/mL of the stem-bark extract, 59.85–66.82 percentage inhibition was obtained. There was a non-significant increase in the extract inhibition of the α-glucosidase and α-amylase at the concentrations of 100–300 mg/mL. At 500 mg/mL, the percentage inhibition of α-glucosidase (71.21) was significantly high (p > 0.05), when compared to the percentage inhibition of α-amylase at the same concentration.

Bioinformatic studies of the interaction of Newbouldia laevis flavonoids with some enzymes

In this study, the compound library was docked against some of the targets for diabetic complications, including α-Glucosidase (PDB ID: 2JKP), α-amylase (PDB ID: 2QMK), Phospholipase A2 (PDB ID: 1G4I), Acetylcholinesterase (PDB ID: 2ACE) and Butyrylcholinesterase (PDB ID: 6QAE) and the binding energies obtained in Kcal/mol for the best-docked position are reported in Table 5

Table 5 Binding energies/affinities of compounds (Kcal/mol)


The antioxidant abilities of plants rich in phenolics are considered as a good source medication for various disease condition. [26, 27] had shown that the leaf extract of N. laevis contains high phenolics. This is in tandem with [9] reports. In the report of [26], alkaloids, flavonoids, saponins and steroids were not detected in the extract of N. laevis leaf. Also, Usman and Osuji [27] did not report that alkaloids and saponins were detected in their study. Whereas, tannins, flavonoids, alkaloids, saponins, and steroidal glycosides were detected in the study of Josiah and Bartholomew [28]. [26] had reported the type of solvents, geographical location, season and time of plant material harvest as some factors that affect the phytochemicals present in plant extracts. The medicinal properties such as the anti-diabetic activity of plant extracts have been attributed to the high concentration of alkaloids and flavonoids [20]. The high concentration of these phytochemicals in the N. laevis extract makes it a good antidiabetic agent. Flavonoids are shown to have pharmacological activities. Quercetin has important pharmacological functions such as the neuroprotective and cardioprotective ability [29]. One of the antioxidant compounds is catechin [30], which is involved in the protection of the skin [31]. Isorhamnetin and naringin were reported to possess anti-inflammatory and antioxidative functions, tumor-inhibiting and bone regeneration [32, 33]. The inhibitory activity could be due to a high concentration of flavonoids, including luteolin, myricetin and quercetin, which have been previously reported to possess α-amylase inhibitory ability [34]. The medicinal potential of plant-based material could be attributed to high flavonoid concentration [35]. Flavonoids have been reported to possess various pharmacological potentials. [35] reported epicatechin and epigallocatechin gallate possess known insulin-like properties and hypoglycemic agents. Thus, the presence of high flavonoid concentration exerts most of the pharmacological activities observed in the N. laevis extract.

Several plant extracts have been reported to possess reactive radical scavenging abilities, and this potential could be due to the presence of polyphenolic compounds [24, 34]. Here, the DPPH scavenging ability of the extract was comparable to reports on N. laevis leaf. Also, the presence of tannins in the extract would have aided in exerting the antioxidant potential obtained. Tannins have been earlier reported to possess free radicals scavenging power [36]. Similarly, alkaloids were reported to exert antioxidant activity [37], antimalaria and antihypertensive activities [38]. Flavonoids are a potent antioxidant agent [39] and anticarcinogenic agent [40].

Table 2 shows the antioxidant potential of the stem-bark extract of N. laevis. One of the significant indicators of the antioxidant activity of a compound is its ability to transfer electrons [41]. There was a significant difference in the metal chelating ability of this extract (p > 0.05) among 100, 200 and 500 mg/mL, when compared to 300 mg/mL (53.94) and Vit C (59.33%), respectively. A similar result was obtained for the metal chelating ability of the extract, where 300 mg showed a significantly higher (p > 0.05) chelating ability than other concentrations studied.

Though different parts of the N. laevis plant have been reported to possess antioxidant activity, the stem-bark extract studied proved to possess more antioxidant activity when compared to other parts of the plant. The OH* scavenging activity of N. laevis stem-bark (60.27%) is higher when compared to 44.5% obtained for N. laevis leaf extract as reported by [42] and 42% (0.42 mg/mL) reported by [43]. The FRAP potential of the stem-bark extract (57.33%) is higher compared to value obtained by [28] for N. laevis leaf extract. The data obtained for the stem-bark extract suggest it possess more antioxidant power than other parts of the plant.

The excessive expression of some physiological enzymes (α-amylase, phospholipase A2 and α-glucosidase) is implicated in the etiology of diabetes Alzheimer's disease [40, 41], inflammation [44] and hypertension [40, 45]. Thus, this study investigated the in vitro bioactivity of Newbouldia laevis stem-bark on acetylcholinesterase, butyrylcholinesterase, α-amylase, phospholipase A2, and α-glucosidase enzymes. The control of these enzymes (inhibition) has been reported as an effective method of managing or curing these diseases. Due to their availability, affordability and minimal known side effects, Phyto-therapies are becoming highly recommended and practiced.

Though, non-significant (p > 0.05) inhibition of the enzyme was obtained when compared between the cholinesterases. Generally, the extract showed more inhibition of BuchE than AchE at 200, 300 and 500 mg/mL (Table 3). 68–74% inhibition of AchE and BuchE was obtained by the flavonoid-rich extract as reported by [46] Also, the high inhibition ability of cholinesterase was reported by [47], of the extract of C. albidum, while a low inhibition value was obtained for AchE as reported by [48]. Flavonoids are known to exert anticholinesterase activity [49], which implies their implication in the management of neurodegenerative diseases.α-amylase is essential in the digestion of carbohydrates, which involves the hydrolysis of starch to oligosaccharide [34]. These are further metabolized by α-glucosidases to glucose which then enters the bloodstream. Rapid breakdown of dietary starch will lead to consistent elevated post-prandial hyperglycemia. Thus, the inhibition of these enzymes will reduce the concentration of post-prandial glucose. World Health Organization during the Traditional Medicine Strategy 2002–2005 in Geneva, Switzerland, in 2002 had stated that one approach to controlling high blood glucose concentration is by inhibiting amylase and glucosidase.

Flavonoid is a known as potent inhibitors of carbohydrase [50]. Previous research reported IC50of 0.36–50 mM of flavonoids on α-amylase [34], while the extract of guava leaf gave IC50 of 4.3–4.8 mM for α-amylase inhibition. A low IC50 of 74.35 mg/mL was obtained for the inhibition of α-amylase by M. indica [51], compared to 243.06 mg/mL obtained in this study. Tannins were also reported as potent inhibitors of α-amylase’ [52], while IC50 of 23.05 mg/mL was obtained for phenolic compounds [53]. Also, a lower IC50 of 83.72 mg/mL was obtained for the inhibition of α-amylase by alkaloids [54]. Likewise, terpenoids have been reported to have α-amylase inhibitory properties [55]. A lower IC50 (5.43–0.9 µg/mL) was reported for the inhibition of the enzymes [20]. High inhibition concentrations (IC50) of 243.06 and 251.04 mg/mL were obtained for the extract on the α-amylase and α-glucosidase, respectively.

Molecular docking analysis fosters the prediction of the nature of binding interactions between a drug or phytochemical (ligand) and its protein targets (usually referred to as the receptors) [56]. Newbouldia laevis has been shown to possess diverse bioactivities, especially for managing diabetic conditions and their associative complexities. Some of these diabetic complexities include sensory disorders, neurological, systemic inflammation, retinopathy, and others. Using HPLC analysis, the phytoconstituents of the flavonoid extract of N. laevis were obtained and used to construct the phytochemical library. The compounds obtained are majorly flavonoids and polyphenolics, including apigenin, catechin, quercetin, kaempferol, isorhamnetin, naringenin, and luteolin. The 2D and 3D structures of the compounds were retrieved from the PubChem database ( They were used for molecular docking to physiological enzymes and its complexities, including α-Amylase, α-Glucosidase, acetylcholinesterase (AChE) butyrylcholinesterase (BuChE), and Phospholipase A2.

In detail, α-Amylase and α-Glucosidase are enzymes that foster carbohydrate digestion, thereby increasing the postprandial glucose level in diabetic patients; hence, inhibiting these enzymes can be a management option against diabetes [53, 54]. In the same vein, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) are key enzymes in several neurological disorders. Their inhibition provides an option in the management of neurological disorders. Recent studies have reported the elevation of these enzymes in the blood of diabetic patients, just as in the neurological condition of Alzheimer's disease [49]. Moreover, lastly, Phospholipase A2 (PLA2) is another key enzyme prominent in several inflammatory conditions, especially in diabetics, such as retinopathy, periodontitis, and others. The PLA2 enzymes specifically foster the release of arachidonic acid to generate lipid mediators of inflammation [57]. Therefore, the management of diabetes and its complexities can be better achieved through a multi-targeted approach to discovering a drug or drugs with multi-inhibitory activities against different enzymes involved in the etiology of diabetes.

The binding energy measures the relative affinities or strength of interaction between a ligand in its target. The higher the negative value of binding energy, the better the ligand-receptor interaction or binding affinities. The binding energies of the different phytochemicals against the various targets, as reported in Table 5, showed better interactions of the phytochemicals within the binding pocket of the receptors than both the standard drugs and co-crystallized ligands. Moreover, all the phytocompounds showed significant activities against AChE, α-Glucosidase, and α-Amylase. Whereas, against butyrylcholinesterase and Phospholipase A2, the affinities were similar to the standard drugs. Although all the phytochemicals identified from the ethanol extract of Newbouldia laevis stem-bark showed interesting affinities to the different targets, naringenin had the best binding affinity among others toward all the targets except α-glucosidase. Based on the docking result from Table 5, the plant's phytochemicals can be ranked based on their potencies against diabetes complexities as naringenin > Luteolin > Quercetin > Isorhamnetin > catechin > apigenin > kaempferol. Examining the 2D interaction of the phytochemicals against binding pocket amino acids of the various targets showed the common existence of hydrogen bonding to residues like aspartate, glutamate, histidine, arginine and others. Moreover, other weak interactions such as Vander Waals interaction and different pi-pi interactions among aromatic rings existed among atoms of the phytochemical and amino acids in the active site of the target (Figs. 3, 4, 5, 6, 7). The 3D structures (Figs. 8, 9, 10, 11, 12) indicated that the phytocompounds from the N. laevis bind deeply into the enzyme's active site, rather than just a shallow or surface binding. Deeply bound compounds usually indicate a more stable interaction than shallow binders, although there is a need for more advanced molecular dynamic simulations and DFT analysis to ascertain the claim. In addition to the high binding affinity, all phytochemicals showed insignificantly or zero toxicity from the toxicity prediction analysis reported in Table 6. This in silico toxicity prediction is consistent with in vitro toxicity studies on the plant, reporting their non-toxicities in several animal models and cell lines.

Fig. 3
figure 3

2D views of interactions with acetylcholinesterase

Fig. 4
figure 4

2D views of interactions with amylase

Fig. 5
figure 5

2D views of interactions with phospholipase A2

Fig. 6
figure 6

2D views of interaction of butyrylcholinesterase

Fig. 7
figure 7

2D views interaction of α-glucosidase

Fig. 8
figure 8

3D views of interactions with acetylcholinesterase

Fig. 9
figure 9

3D views of interactions with α-amylase

Fig. 10
figure 10

3D views of interactions with phospholipase A2

Fig. 11
figure 11

3D views of interaction of butyrylcholinesterase

Fig. 12
figure 12

3D views interaction of α-glucosidase

Table 6 Predicted toxicity analysis

In summary, our findings are similar to in silico studies, with several studies conducted singly against the identified phytochemicals and several targets [56, 58, 59]. In a recent study, naringenin and other interesting flavonoid derivatives were synthesized and shown to possess vitro AChE inhibitory activities (IC50 < 100 μM) [60]. Similarly, in in vitro and in silico studies, luteolin exhibited exciting inhibitory activities against α-glucosidase [61]. More so, apigenin isolated alongside other flavonoids from the extract and the flavonoid-rich fraction of Merremia tridentata (L.) showed remarkable antidiabetic properties in vitro [62]. Although these phytochemicals in our plant extract and their impressive binding properties to various targets promise tremendous therapeutic activities against diabetic complications, there is a need for in vivo and other in vitro studies on cell cultures to corroborate these findings.


The research presented the flavonoids fingerprint of N. laevis stem-bark extract which showed high concentrations of catechin, apigenin, luteolin, kaempferol and quercetin, respectively, which are efficacious flavonoids with proven bioactivities. Also, the power to scavenge radicals generated in vitro suggests it could be a good antioxidant agent. The extract showed good attributes of an antidiabetic agent due to its ability to inhibit α-glucosidase and α-amylase with inhibition constants (Ki) of 2.95 and 2.11, respectively, and its potential to ameliorate other complications associated with diabetes by inhibiting AchE, BuchE and PLA2. The power of the extract to mop up some radicals and inhibit some of these physiological enzymes in vitro suggests that the stem bark could be effective in ameliorating the complications associated with diabetes.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author, upon reasonable request.



Gas chromatography/flame ionization detector


High-performance liquid chromatography




Hydroxyl radical


Sulfoxide radical


Nitric oxide radical

PLA2 :

Phospholipase A2


Inhibition constant


Protein data bank






  1. Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, Anand BDP, Tiroyakgosi C, Okwen PM, Niba LL, Nonvignon J, Sefah I, Oluka M, Guantai AN, Kibuule D, Kalemeera F, Mubita M, Fadare J, Ogunleye OO, Distiller LA, Rampamba EM, Wing J, Mueller D, Alfadl A, Amu AA, Matsebula Z, Kalungia A, Zaranyika T, Masuka N, Wale J, Hill R, Kurdi A, Timoney A, Campbell S, Meyer JC (2020) Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol 11:108.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wang J, Li L, Wang Z, Cui Y, Tan X, Yuan T, Liu Q, Liu Z, Liu X (2018) Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress. J Nutr Biochem 56:16–25.

    Article  CAS  PubMed  Google Scholar 

  3. Diabetes Atlas, the seventh edition, 2015.

  4. Pollack RM, Donath MY, LeRoith D, Leibowitz G (2016) Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care 39(Suppl 2):S244–S252.

    Article  CAS  PubMed  Google Scholar 

  5. Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment. Br J Clin Pharmacol 71:365–376.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Agatemor UM, Nwodo FOC, Ozah IR (2019) Inhibition of phospholipase A2 and prostaglandin synthase activities as possible mechanisms for the anti-inflammatory effect of cucumis sativus fruit homogenate. Acta Sci Pharm Sci 3:68–73.

    Article  Google Scholar 

  7. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Millogo-Kone H, Guissou I, Nacoulma O, Traore AS (2008) Comparative study of leaf and stem bark extracts of Parkia biglobosa against enterobacteria. Afr J Tradit Complement Altern Med 5:238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Anaduaka EG, Ogugua VN, Egba SI, Apeh VO (2016) Investigation of some important phytochemical, nutritional properties and toxicological potentials of ethanol extracts of Newbouldia laevis leaf and stem. Afr J Biotech 12:5941–5949.

    Article  Google Scholar 

  10. Akerele JO, Ayinde BA, Ngiagah J (2011) Phytochemical and antibacterial evaluations of the stem bark of Newbouldia laevis against isolates from infected wounds and eyes. Trop J Pharm Res 10:211–218.

    Article  Google Scholar 

  11. Ejele A, Duru I, Ogukwe C, Iwu I (2012) Phytochemistry and antimicrobial potential of basic metabolites of Piper Umbellatum, Piper Guineense, Ocimum Gratissimium and Newbouldia Laevis extracts (Unpublished)

  12. Ogunlana OE, Ogunlana OO (2008) In vitro assessment of antioxidant activity of Newbouldia laevis. J Med Plants Res.

  13. Oloyede FA, Oloyede FM (2014) The antioxidant and food value of Chrysophyllum albidium G. Don. Sch J Agric Vet Sci 1(1):1–5

    Google Scholar 

  14. Oyeka EE, Asegbeloyin JN, Babahan I, Eboma B, Okpareke O, Lane J, Ibezim A, Bıyık HH, Törün B, Izuogu DC (2018) Synthesis, crystal structure, computational analysis and biological properties of 1-(4-chlorobenzoyl)-3-[2-(2-{2-[3-(4-chlorobenzoyl)-thioureido]-ethoxy}ethoxy)ethyl]-thiourea and its Ni(II) and Cu(II) complexes. J Mol Struct 1168:153–164.

    Article  CAS  Google Scholar 

  15. Shen X, Chen W, Zheng Y, Lei X, Tang M, Wang H, Song F (2017) Chemical composition, antibacterial and antioxidant activities of hydrosols from different parts of Areca catechu L. and Cocos nucifera L. Ind Crops Prod 96:110–119.

    Article  CAS  Google Scholar 

  16. Jin H, Cia M, Li Y, Zhou J (1996) 1,10-phenanthroline-Fe2+ oxidative assay of hydroxyl radical produced by H2O2/Fe—ScienceOpen. Prog Biochem Biophys 23:553–555

    CAS  Google Scholar 

  17. Beauchamp C, Fridovich I (1997) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44:276–287.

    Article  Google Scholar 

  18. Sangameswaran BB, Balakrishnan B, Deshraj BR, Jayakar C (2009) In vitro antioxidant activity of roots of Thespesia lampas Dalz and Gibs—PubMed. Pak J Pharm Sci 22:368–372

    CAS  PubMed  Google Scholar 

  19. Oyaizu M (1986) Studies on products of browning reaction. Antioxidative activities of products of browning reaction prepared from glucosamine. Jpn J Nutr Dietetics 44:307–315.

    Article  CAS  Google Scholar 

  20. Gulati V, Harding IH, Palombo EA (2012) Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Complement Altern Med 12:1–9.

    Article  Google Scholar 

  21. Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD (2005) Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol 99:239–244.

    Article  PubMed  Google Scholar 

  22. Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and Multithreading. J Comput Chem.

    Article  Google Scholar 

  23. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminform.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612.

    Article  CAS  PubMed  Google Scholar 

  25. Khan MTH, Orhan I, Şenol FS, Kartal M, Şener B, Dvorská M, Šmejkal K, Šlapetová T (2009) Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem Biol Interact 181:383–389.

    Article  CAS  PubMed  Google Scholar 

  26. Omeje KO, Ezema BO, Ozioko JN, Omeje HC, Ogidigo JO, Okeke OR, Nnorom CO (2020) Cholinesterases inhibition and antioxidant potentials of newbouldia laevis and ficus exasperata vahl leaf extract. Pharmacologyonline 1:77–91

    CAS  Google Scholar 

  27. Usman H, Osuji JC (2007) Phytochemical and in vitro antimicrobial assay of the leaf extract of Newbouldia laevis. Afr J Tradit Complement Altern Med 4:476.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Habu JB, Ibeh BO (2015) In vitro antioxidant capacity and free radical scavenging evaluation of active metabolite constituents of Newbouldia laevis ethanolic leaf extract. Biol Res.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Costa LG, Garrick JM, Roquè PJ, Pellacani C (2016) Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxid Med Cell Longev.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Bernatoniene J, Kopustinskiene DM (2018) The role of catechins in cellular responses to oxidative stress. Molecules (Basel, Switzerland) 23(4):965.

    Article  PubMed  Google Scholar 

  31. Clarke KA, Dew TP, Watson REB, Farrar MD, Osman JE, Nicolaou A, Rhodes LE, Williamson G (2016) Green tea catechins and their metabolites in human skin before and after exposure to ultraviolet radiation. J Nutr Biochem 27:203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Li W, Chen Z, Yan M, He P, Chen Z, Dai H (2016) The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation. J Neurochem 136:651–659.

    Article  CAS  PubMed  Google Scholar 

  33. Chen R, Qi QL, Wang MT, Li QY (2016) Therapeutic potential of naringin: an overview. Pharm Biol 54:3203–3210.

    Article  CAS  PubMed  Google Scholar 

  34. Kumar S, Kumar V, Rana M, Kumar D (2012) Enzymes inhibitors from plants: an alternate approach to treat diabetes. Pharmacogn Commun 2:18–33.

    Article  Google Scholar 

  35. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ (2006) Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 106:1–28.

    Article  CAS  PubMed  Google Scholar 

  36. Deng L, Qi Y, Liu Z, Xi Y, Xue W (2019) Effect of tannic acid on blood components and functions. Colloids Surf B Biointerfaces.

    Article  PubMed  Google Scholar 

  37. Patel K, Gadewar M, Tripathi R, Prasad SK, Patel DK (2012) A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid ‘“Harmine”,.’ Asian Pac J Trop Biomed 2:660.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kuete V, Efferth T (2015) African flora has the potential to fight multidrug resistance of cancer. Biomed Res Int.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Srivastava J, Kumar S, Vankar PS (2012) Correlation of antioxidant activity and phytochemical profile in native plants. Nutr Food Sci 42:71–79.

    Article  Google Scholar 

  40. Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:1–15.

    Article  Google Scholar 

  41. Falode JA, Obafemi TO, Akinmoladun AC, Olaleye MT, Boligon AA, Athayde ML (2018) High-performance liquid chromatography (HPLC) fingerprinting and comparative antioxidant propeties of rootbark and leaf extracts of Calliandra portoricensis. Phytochemical Research Laboratory, Department of Industrial Pharmacy, Federal University of I, 1

  42. Salemcity AJ, Nwaneri-Chidozie VO, Adameh E, Eno Effiong M (2020) Antioxidant and free radical scavenging activities of Newbouldia laevis leaf extracts. Free Radic Antioxid 10:10–15.

    Article  CAS  Google Scholar 

  43. Akomolafe SA, Oyeleye SI, Olasehinde TA, Oboh G (2018) Phenolic characterization, antioxidant activities, and inhibitory effects of Physalis angulata and Newbouldia laevis on enzymes linked to erectile dysfunction. Int J Food Prop 21:645–654.

    Article  CAS  Google Scholar 

  44. Ibezim A, Onoabedje EA, Adaka IC, Omeje KO, Onoabedje US, Obi BC (2020) Carboxamides bearing sulfonamide functionality as potential novel phospholipase A2 inhibitors. ChemistrySelect 5:14416–14421.

    Article  CAS  Google Scholar 

  45. Adisakwattana S, Ruengsamran T, Kampa P, Sompong W (2012) In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med 12:1–8.

    Article  Google Scholar 

  46. Urama DC, Omeje KO, Ezema BO, Ozioko JN, Omeje HC, Ezinne U (2020) High performance liquid chromatography profiling of dennettia tripetala leaf extract and its biological activities. Trop J Nat Prod Res 4:995–999.

    Article  CAS  Google Scholar 

  47. Ezema BO, Omeje KO, Ozioko JN, Urama DC, Omeje HC, Nnawulezi A, Ejim A (2021) Cholinesterase inhibition, biological activity and characterization of Chrysophyllum albidum leaf and stem-bark chloroform extract using GC-MS: an in vitro study. Trop J Nat Prod Res 4(11):995–999.

    Article  CAS  Google Scholar 

  48. Oboh G, Adebayo AA, Ejakpovi II, Ogunsuyi OB, Boligon AA (2018) Phenolic profiling and in vitro antioxidant, anticholinesterase, and antimonoamine oxidase properties of aqueous extract of African star apple (Chrysophyllum albidum) fruit parts. J Food Biochem 42:e12568.

    Article  Google Scholar 

  49. Mushtaq G, Greig N, Khan J, Kamal M (2014) Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 13:1432–1439.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Zengin G, Guler GO, Aktumsek A, Ceylan R, Picot CMN, Mahomoodally MF (2015) Enzyme inhibitory properties, antioxidant activities, and phytochemical profile of three medicinal plants from Turkey. Adv Pharmacol Sci.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Dineshkumar B, Mitra A, Mahadevappa M (2010) Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from Murraya koenigii (rutaceae) leaves. Int J Phytomed 2:22–30.

    Article  CAS  Google Scholar 

  52. Hosoyama H, Sugimoto A, Suzuki Y, Sakane I, Kakuda T (2003) Isolation and quantitative analysis of the α-amylase inhibitor in Lagerstroemia speciosa (L.) Pers. (Banaba). Yakugaku Zasshi.

    Article  PubMed  Google Scholar 

  53. Shobana S, Sreerama YN, Malleshi NG (2009) Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: mode of inhibition of α-glucosidase and pancreatic amylase. Food Chem 115:1268–1273

    Article  CAS  Google Scholar 

  54. Dineshkumar B, Mitra A, Manjunatha M (2010) Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (Xanthone Glucoside) in streptozotocin-induced Type 1 and Type 2 diabetic model rats. Int J Adv Pharm Sci 1:75–85.

    Article  CAS  Google Scholar 

  55. Ali H, Houghton PJ, Soumyanath A (2006) alpha-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 107:449–455.

    Article  PubMed  Google Scholar 

  56. Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP (2019) Key topics in molecular docking for drug design. Int J Mol Sci.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Batsika CS, Gerogiannopoulou ADD, Mantzourani C, Vasilakaki S, Kokotos G (2021) The design and discovery of phospholipase A 2 inhibitors for the treatment of inflammatory diseases. Expert Opin Drug Discov 16:1287–1305.

    Article  CAS  PubMed  Google Scholar 

  58. Mwakalukwa R, Amen Y, Nagata M, Shimizu K (2020) Postprandial hyperglycemia lowering effect of the isolated compounds from olive mill wastes—an inhibitory activity and kinetics studies on α-glucosidase and α-amylase enzymes. ACS Omega 5:20070–20079.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Poovitha S, Parani M (2016) In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement Altern Med.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Tran TH, Vo TTH, Vo TQN, Cao TCN, Tran TS (2021) Synthesis and evaluation of the acetylcholinesterase inhibitory activities of some flavonoids derived from naringenin. Sci World J.

    Article  Google Scholar 

  61. Djeujo FM, Ragazzi E, Urettini M, Sauro B, Cichero E, Tonelli M, Froldi G (2022) Magnolol and luteolin inhibition of α-glucosidase activity: kinetics and type of interaction detected by in vitro and in silico studies. Pharmaceuticals 15:205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Vo Van L, Pham EC, Nguyen CV, Duong NTN, Vi Le Thi T, Truong TN (2022) In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.). Biomed Pharmacother 146:112611.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors would like to thank the department of Biochemistry University of Nigeria, Nsukka for providing the laboratory space for this work.


There was no external funding received for this study.

Author information

Authors and Affiliations



KOO and SOOE contributed to conceptualizing the work, validation of the work and drafted the paper; BOE and CNO performed the experiment, revised the draft paper. SCO contributed to data analysis; TPCE interpreted data and methodology. All the authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Benjamin O. Ezema.

Ethics declarations

Ethics approval and consent to participate

Not applicable for this work. Newbouldia laevis stem bark was used in this study. The plant/plant part was provided and identified by Mr Felix Nwafor of the department of plant science and biotechnology, University of Nigeria, Nsukka and deposited as Newbouldia laevis G. Don. (Sapotaceae) with voucher number PCG/UNN/0359. The study was approved by the ethics committee of the Faculty of Biological Sciences, University of Nigeria, Nsukka, with reference Number FBS/2022/00183.

Consent for publication

The authors declare no conflict of interest.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

HPLC data for N. laevis flavonoids.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omeje, K.O., Ezema, B.O., Onaebi, C.N. et al. HPLC fingerprint of flavonoids, enzyme inhibition and antioxidant activity of Newbouldia laevis stem-bark: an in vitro and in silico study. Futur J Pharm Sci 9, 36 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: